Dr Anna Britten

Dr Anna Britten is a highly regarded Consultant Clinical Oncologist who specialises in the non-surgical treatment of cancers, with a particular focus on thoracic malignancies. Reassuring and dedicated, she is committed to providing comprehensive, patient-centred care. Dr Britten works closely with multidisciplinary teams to design personalised treatment pathways that address the unique needs of each individual, ensuring they receive the highest standard of care throughout their oncology journey.

In her clinical practice, Dr Britten specialises in treating all types of lung cancer. She is highly skilled in delivering a wide range of advanced therapeutic options, including systemic therapies such as chemotherapies, immunotherapies, and targeted molecular therapies. Additionally, she has extensive expertise in modern radiotherapy techniques, with a particular interest in stereotactic ablative radiotherapy (SABR). Her clinical focus centres on implementing these advanced, highly precise treatments to target tumours effectively while minimising side effects and preserving patient well-being.

Dr Britten completed her comprehensive specialist oncology training at several of the world's leading cancer centres, located in Manchester, London, and Paris. This international training has provided her with a deep understanding of cutting-edge oncological practices and global standards of care. Alongside her clinical work, she is actively involved in clinical research and service development, with a focus on accelerating diagnostic pathways and improving patient outcomes through innovative radiotherapy solutions. She is fully registered with the General Medical Council and maintains active engagement with professional oncology bodies to ensure her practice remains at the forefront of medical advancement.